Chromosome aberrations in de novo acute myeloid leukemia patients in Kuwait

Neoplasma

Volumn 51, Issue 3, 2004, Pages 223-227

  Al Bahar, S ^a   Zamecnikova, A ^a   Pandita, R ^a   Bavishi, K ^a   Kreze, O ^a   Nath, S ^a  

^a KUWAIT CANCER CONTROL CENTER   (Kuwait)

Author keywords

Acute myeloid leukemia; Cancer cytogenetics; Chromosomal abnormalities

Indexed keywords

TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER PATIENT; CHILD; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CLONE; FEMALE; HUMAN; KARYOTYPE; KUWAIT; MAJOR CLINICAL STUDY; MALE; MONOSOMY 7; PROGNOSIS; RECURRENCE RISK; TRISOMY 8;

EID: 3042618932     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. AL-BAHAR S, PANDITA R, AL-MUHANNAHA A, AL-BAHAR E. The epidemiology of leukemia in Kuwait. Leukemia Research 1994; 4: 251-255.
2. Atlas of Genetics and Cytogenetics in Oncology and Haematology 1998. www.infobiogen.fr//services/chromcancer/Anomalies/Anomliste.html.
3. CALIGURI AM, STROUT MP, GILLILAND DG. Molecular biology of acute myeloid leukemia. Semin Oncol 1997; 24: 32-44.
4. GILES FJ, KEATING A, GOLDSTONE AH, AVIVI I, WILLMAN CL, KANTARJIAN HM. Acute myeloid leukemia. Hematology 2002; 1: 73-110.
5. GRIMWADE D, WALKER H, OLIVER F, WHEATLEY K, HARRISON CJ et al. On behalf of the MRC adult and children's leukemia working parties, the importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998; 92: 2322-2333.
6. GRIMWADE D, WALKER H, HARRISON G, OLIVER G, CHATTERS Set al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 Trial. Blood 2001; 98: 1312-1320.
7. MAURITZSON N, ALBIN M, RYANDER L, BILLSTORM R, AHLGREN T et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 974-2001. Leukemia 2002; 16: 2366-2378.
8. MITELMAN F. ISCN 1995. An International System for Human Cytogenetic Nomenclature. Basel, Karger, Switzerland, 1995.
9. MROZEK K, HEINONEN K, DEL LA, CHAPELLE A, BLOOMFIELD CD. Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 1997; 24: 17-31.
10. PEDERSEN-BJERGAARD J, ANDERSEN MK, CHRISTIANSEN DH, NERLOV C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 2002; 99: 1909-1912.
11. RAIMONDI SC, CHANG MN, RAVINDRANATH G, BEHM FG, GRESIK MV et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a Cooperative Pediatric Oncology Group study-POG 8821. Blood 1999; 94: 3707-3716.
12. SLOVAK ML, KOPECKY KJ, CASSILETH P, HARRINGTON DH, THEIL KS et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 2000; 96: 4075-4083.
13. SWEETSER DA, CHEN CS, BLOMBERG AA, FLOWERS DA, GALIPEAU PC et al. Loss of heterozygosity in childhood de novo acute myelogenous leukemia. Blood 2001; 98: 1188-1194.
14. VARDIMAN JW, HARRIS NL, BRUNNING RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 7: 2292-2302.